• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

    3/31/26 10:12:55 AM ET
    $SBC
    Medical/Nursing Services
    Health Care
    Get the next $SBC alert in real time by email

    PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (NASDAQ:SBC), a Japan-based management services organization building a large and growing global aesthetic medical network.

    In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy.

    The Q&A highlights several key themes, including:

    • Improving unit economics, with Q4 average revenue per visit increasing 11% year over year to $316, signaling a recovery following a multi-quarter compression trend
    • Strategic U.S. expansion through a minority investment in OrangeTwist, a premium medspa platform, marking SBC's entry into the American market
    • A differentiated, capital-light business model that has generated EBITDA margins above 40% across a network of 283 locations and 6.63 million annual patient visits
    • A disciplined transition year in 2025, where revenue declined due to intentional structural changes while net income grew 9% and margins remained intact
    • A strong balance sheet, with $164 million in cash and low leverage, providing flexibility for M&A and continued expansion
    • Long-term growth initiatives, including AI-driven operational infrastructure and the expansion of SBC Wellness 2.0 into Japan's $34 billion longevity market

    "The recovery in average revenue per visit is the clearest signal of improving unit economics."

    The discussion also explores SBC's positioning in the fragmented U.S. aesthetic market, where management believes its system-driven approach to clinical quality, customer retention, and operational efficiency can differentiate the platform as it scales internationally.

    "Few operators have built systems that replicate quality at scale. That is the system we are introducing into the U.S. market."

    The full Q&A, published by PRISM MarketView, is available here: https://prismmarketview.com/q4-2025-earnings-beat-orangetwist-partnership-update-and-growth-strategy/

    Watch SBC Medical's latest earnings presentation: https://youtu.be/CUujUbs7vo8

    SBC Media Group YouTube Channel: https://www.youtube.com/@SBCMedicalGroupHoldings

    About SBC Medical

    SBC Medical Group Holdings Incorporated is a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care. For more information, visit https://sbc-holdings.com/.

    About PRISM MarketView

    PRISM MarketView is a financial media platform covering emerging growth companies and sector innovation across public markets. Through original editorial, video features, and executive Q&A content, PRISM provides timely market intelligence and expanded visibility for high-potential companies. The platform maintains a suite of proprietary indexes tracking momentum across sectors including AI infrastructure, biotech, space, precious metals, NextGen Tech and AI, and psychedelics, among others. Learn more at www.prismmarketview.com.

    PRISM MarketView does not provide investment advice.

    Forward-Looking Statements

    This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's financial performance; growth in revenue and earnings; business prospects and opportunities; and capital deployment plans and liquidity. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.

    Disclaimer

    This communication was produced by PRISM MarketView. PRISM MarketView is not a registered or licensed broker-dealer nor investment adviser. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security. PRISM MarketView may be compensated by respective clients for publicizing information relating to its clients' securities. For full disclaimer, visit: https://prismmarketview.com/disclaimer/

    Contact:

    PRISM MarketView

    [email protected]

    646-863-6341

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5bbc7cc7-f33c-4fcf-a2fc-f3506fcbd33f

    A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/51fafc68-d841-4fb0-a6ea-ef411e11e7ad

     



    Primary Logo

    Get the next $SBC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SBC

    DatePrice TargetRatingAnalyst
    3/6/2026$8.00Buy
    BTIG Research
    More analyst ratings

    $SBC
    SEC Filings

    View All

    SEC Form 10-K filed by SBC Medical Group Holdings Incorporated

    10-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 7:31:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    3/27/26 6:50:43 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - SBC Medical Group Holdings Inc (0001930313) (Filer)

    1/5/26 7:00:29 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PRISM MarketView Features Exclusive Q&A with SBC Medical CEO Yoshiyuki Aikawa on Growth Strategy, U.S. Expansion, and Improving Unit Economics

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView today published an exclusive Q&A feature with Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical Group Holdings (NASDAQ:SBC), a Japan-based management services organization building a large and growing global aesthetic medical network. In the interview, Aikawa discusses SBC Medical's evolution from a domestic platform into a globally scalable model, as well as the company's recent operational inflection, U.S. market entry, and long-term growth strategy. The Q&A highlights several key themes, including: Improving unit economics, with Q4 average revenue per visit increasing 11% year over year to $316, signa

    3/31/26 10:12:55 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Announces Next-Generation Wellness Strategy "SBC Wellness 2.0"

    Pioneering the "Performance Medicine" category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced "SBC Wellness 2.0," a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/SBC Medical Announces Next-Generation Wellness

    3/24/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by SBC Medical Group Holdings Incorporated

    4 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    3/10/26 9:54:07 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SEC Form 3 filed by new insider Yamazaki Miki

    3 - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/18/25 4:56:42 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: New insider Aikawa Yoshiyuki claimed ownership of 94,192,433 shares (SEC Form 3)

    3/A - SBC Medical Group Holdings Inc (0001930313) (Issuer)

    4/9/25 7:00:13 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Financials

    Live finance-specific insights

    View All

    SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results

    Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year

    3/27/26 6:40:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results

    IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.  Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company's financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remark

    3/13/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 mill

    11/14/25 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Leadership Updates

    Live Leadership Updates

    View All

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints Dr. Steven R. Cohen as Medical Strategy Advisor to Accelerate Global Expansion

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company's strategy to expand its global footprint and enhance its medical excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250714547888/en/Dr. Cohen Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center

    7/14/25 9:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    SBC Medical Appoints New Chief Marketing Officer to Enhance Marketing Infrastructure and Strengthen Brand Power

    IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025. As CMO of SBC Medical, Mr. Inoue will lead efforts to enhance the brand value of the group's portfolio, including Shonan Beauty Clinic, one of Japan's largest aesthetic medical brands. He will also spearhead the evolution and optimization of the company's marketing infrastructure with a strong focus on digital innovation. Through strategic initiatives that address the increasing diversity of

    7/1/25 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    $SBC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    10/1/24 9:00:18 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/24/24 9:07:03 PM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by SBC Medical Group Holdings Incorporated

    SC 13D/A - SBC Medical Group Holdings Inc (0001930313) (Subject)

    9/23/24 9:02:53 AM ET
    $SBC
    Medical/Nursing Services
    Health Care